AGM and Publication of Circular

London, 6 May 2016: NMC Health plc (NMC or the Company) (LSE: NMC), the leading integrated private healthcare provider operating across the United Arab Emirates, and one of the top global providers of fertility treatment, announces circulation of its combined Notice of 2016 Annual General Meeting with related explanatory circular (the Circular).

The Company's 2016 Annual General Meeting (the AGM) will be held on Friday 3 June 2016 at 3.00 pm at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD. The Notice of Meeting with related explanatory circular and the associated Form of Proxy have today been published and posted to shareholders.  A copy of the Circular and the accompanying Form of Proxy have also been submitted to the National Storage Mechanism and will shortly be available for inspection at www.Morningstar.co.uk/uk/NSM.  In addition, the Circular will be available to view on the Company's website http://www.nmchealth.com/shareholder-information/ and available for inspection at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD.

The Circular contains a proposed resolution which will be put to shareholders at the AGM to rectify an issue that the Company has become aware of relating to the procedures followed for the payment of dividends in previous years, being the dividend of 4.1 pence per Ordinary Share paid on 4 July 2013, the dividend of 4.4 pence per Ordinary Share paid on 3 July 2014 and the dividend of 5.4 pence per Ordinary Share paid on 25 June 2015 (the Relevant Distributions). Whilst the Company always had sufficient reserves to pay the Relevant Distributions at the time that they were made, these reserves were not in place at the prior financial year end and therefore the reserves should have been demonstrated by reference to additional interim accounts filed at Companies House prior to each dividend payment. Those interim accounts were not filed with Companies House. This resulted in a technical infringement of the process required by the Companies Act 2006 (the Act).

One of the resolutions being proposed at the AGM is intended to address this situation and put all parties back in the position they were intended to be in had the full technical requirements of the Act been complied with at the time the Relevant Distributions were made. The issue is of an historical nature and there is no change to the financial outlook of the Company as a consequence of this technical matter, the Company's past accounts will not need to be restated and no dividends are expected to be repaid. No fines or other penalties have been incurred by the Company. The proposed steps are in line with those taken by other listed companies that have encountered similar issues. The Circular, which has been approved by the UK Listing Authority, contains full details in relation to this issue.

Contacts

Investors:

NMC   

Simon Watkins, Group Company Secretary              +44 (0)20 3205 7313

Media:

FTI Consulting, London

Matthew Cole                                                              +44 (0)20 3727 1101

FTI Consulting, Gulf

Shane Dolan                                                               +971 (0)4 437 2100

About NMC

NMC Health plc group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. In addition, NMC acquired a 51% shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation (IVF) services. NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 3.2m patients in 2015. The group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Health plc group reported revenues of US$880.9m in 2015.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. NMC Health plc is a constituent of the FTSE 250 Index.